These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 16962929

  • 1. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite.
    Nagassaki S, Sertório JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE.
    Free Radic Biol Med; 2006 Oct 01; 41(7):1044-9. PubMed ID: 16962929
    [Abstract] [Full Text] [Related]

  • 2. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes.
    Metzger IF, Sertório JT, Tanus-Santos JE.
    Free Radic Biol Med; 2007 Sep 15; 43(6):987-92. PubMed ID: 17697943
    [Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene.
    Souza-Costa DC, Sandrim VC, Lopes LF, Gerlach RF, Rego EM, Tanus-Santos JE.
    Atherosclerosis; 2007 Aug 15; 193(2):438-44. PubMed ID: 16938300
    [Abstract] [Full Text] [Related]

  • 4. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity.
    Nagassaki S, Herculano RD, Graeff CF, Tanus-Santos JE.
    Eur J Clin Pharmacol; 2009 Apr 15; 65(4):385-92. PubMed ID: 19104789
    [Abstract] [Full Text] [Related]

  • 5. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia.
    Sandrim VC, Palei AC, Sertorio JT, Cavalli RC, Duarte G, Tanus-Santos JE.
    Mol Hum Reprod; 2010 Jul 15; 16(7):506-10. PubMed ID: 20457799
    [Abstract] [Full Text] [Related]

  • 6. Effects of atorvastatin and T-786C polymorphism of eNOS gene on plasma metabolic lipid parameters.
    Zago VH, Santos JE, Danelon MR, Silva RM, Panzoldo NB, Parra ES, Alexandre F, Virgínio VW, Quintão EC, Faria EC.
    Arq Bras Cardiol; 2013 Jan 15; 100(1):14-20. PubMed ID: 23250834
    [Abstract] [Full Text] [Related]

  • 7. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms.
    Castro MM, Rizzi E, Rascado RR, Nagassaki S, Bendhack LM, Tanus-Santos JE.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):189-94. PubMed ID: 15363994
    [Abstract] [Full Text] [Related]

  • 8. Determination of the effects of eNOS gene polymorphisms (T-786C and Glu298Asp) on nitric oxide levels in a methylmercury-exposed population.
    de Marco KC, Braga GU, Barbosa F.
    J Toxicol Environ Health A; 2011 Sep 13; 74(20):1323-33. PubMed ID: 21899406
    [Abstract] [Full Text] [Related]

  • 9. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
    Momi S, Impagnatiello F, Guzzetta M, Caracchini R, Guglielmini G, Olivieri R, Monopoli A, Gresele P.
    Eur J Pharmacol; 2007 Sep 10; 570(1-3):115-24. PubMed ID: 17632098
    [Abstract] [Full Text] [Related]

  • 10. A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins.
    Lacchini R, Silva PS, Tanus-Santos JE.
    Basic Clin Pharmacol Toxicol; 2010 May 10; 106(5):357-61. PubMed ID: 20210789
    [Abstract] [Full Text] [Related]

  • 11. Clinical evidence for lead-induced inhibition of nitric oxide formation.
    Barbosa F, Sertorio JT, Gerlach RF, Tanus-Santos JE.
    Arch Toxicol; 2006 Dec 10; 80(12):811-6. PubMed ID: 16670857
    [Abstract] [Full Text] [Related]

  • 12. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers.
    Metzger IF, Sertorio JT, Tanus-Santos JE.
    Acta Physiol (Oxf); 2006 Oct 10; 188(2):123-7. PubMed ID: 16948799
    [Abstract] [Full Text] [Related]

  • 13. The -786C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis.
    Melchers I, Blaschke S, Hecker M, Cattaruzza M.
    Arthritis Rheum; 2006 Oct 10; 54(10):3144-51. PubMed ID: 17009241
    [Abstract] [Full Text] [Related]

  • 14. Influence of eNOS gene polymorphisms (894G/T; - 786C/T) on postoperative hemodynamics after cardiac surgery.
    Liakopoulos OJ, Dörge H, Popov AF, Schmitto JD, Cattaruzza M, Schoendube FA.
    Thorac Cardiovasc Surg; 2006 Jun 10; 54(4):233-8. PubMed ID: 16755443
    [Abstract] [Full Text] [Related]

  • 15. Both T-786C and G894T polymorphism of endothelial nitric oxide synthase affect in-vitro endothelium-dependent relaxation of internal mammary artery rings from patients with coronary artery disease.
    Erbs S, Möbius-Winkler S, Linke A, Adams V, Doll N, Gielen S, Gummert JF, Mohr FW, Schuler G, Hambrecht R.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct 10; 13(5):826-31. PubMed ID: 17001225
    [Abstract] [Full Text] [Related]

  • 16. A -786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine.
    Nakayama M, Yoshimura M, Sakamoto T, Abe K, Yamamuro M, Shono M, Suzuki S, Nishijima T, Miyamoto Y, Saito Y, Nakao K, Yasue H, Ogawa H.
    Pharmacogenet Genomics; 2006 May 10; 16(5):339-45. PubMed ID: 16609365
    [Abstract] [Full Text] [Related]

  • 17. Endothelial nitric oxide synthase gene variants contribute to oxidative stress in COPD.
    Arif E, Ahsan A, Vibhuti A, Rajput C, Deepak D, Athar M, Singh B, Pasha MA.
    Biochem Biophys Res Commun; 2007 Sep 14; 361(1):182-8. PubMed ID: 17658478
    [Abstract] [Full Text] [Related]

  • 18. A pharmacogenomic study of atorvastatin effects on eNOS activity: do "statins" modulate blood nitrite levels and intravascular oxidant stress in susceptible individuals?
    Dezfulian C, Raat NJ, Gladwin MT.
    Free Radic Biol Med; 2006 Oct 01; 41(7):1041-3. PubMed ID: 16962928
    [No Abstract] [Full Text] [Related]

  • 19. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
    Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC, Semprini MC, Gerlach RF, Cunha FQ, Tanus-Santos JE.
    Crit Care Med; 2007 Jan 01; 35(1):239-45. PubMed ID: 17133179
    [Abstract] [Full Text] [Related]

  • 20. In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease.
    Aguilar EM, Miralles Jde H, González AF, Casariego CV, Moreno SB, García FA.
    Eur J Vasc Endovasc Surg; 2009 Apr 01; 37(4):443-7. PubMed ID: 19211277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.